REG - Zotefoams PLC - Joint development agreement for ReZorce®

ZotefoamsAnnouncement

18/07/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230718:nRSR2667Ga&default-theme=true

RNS Number : 2667G  Zotefoams PLC  18 July 2023

Zotefoams plc

("Zotefoams" or "Group")

 

Joint development agreement for ReZorce(®) beverage cartons

 

18 July 2023 - Zotefoams, a world leader in cellular materials technology, is
pleased to announce a joint development agreement ("JDA") with a world-leading
packer of beverages. Following successful internal trials, this agreement
encompasses the further development of Zotefoams' ReZorce(®) monomaterial
beverage carton packaging, and its planned use in in-market trials for a major
European retailer.

The JDA covers all activities, including packing at industrial scale, to trial
ReZorce(®) cartons in the retail market and non-binding provisions for
further co-operation. Zotefoams anticipates that the initial scope of work
will continue until early 2024.

ReZorce(®) offers advantages over traditional ("composite") beverage cartons
delivering a lower carbon footprint, recyclability via standard recycling
streams and is designed for the circular economy, initially by using 30%
post-consumer recycled materials. A key factor in securing this agreement is
that ReZorce(®) can be processed on existing packing and filling equipment
and therefore requires minor capital investment by the retailer or packaging
company to commercialise this disruptive technology. No further details of
other parties involved in the JDA are being made available at present, for
reasons of commercial confidentiality.

David Stirling, Zotefoams Group CEO, notes, "This agreement confirms the
significant technical progress we have made with our ReZorce(®) mono-material
barrier range. As we have continued our development efforts, it has become
clear that demand for a sustainable alternative material for beverage cartons
is significant and in line with our initial market assessment.

"This agreement for ReZorce(®) development is an important milestone and we
look forward to it delivering results that clearly demonstrate ReZorce(®) is
the optimal material solution for beverage cartons."

-ENDS-

Enquiries:

 

 Zotefoams plc                         +44 (0) 208 664 1600
 David Stirling, Group CEO

 Gary McGrath, Group CFO

 IFC Advisory (Financial PR & IR)      +44 (0) 203 934 6630
 Graham Herring

 Tim Metcalfe

 Zach Cohen

 

 

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology
delivering optimal material solutions for the benefit of society. Utilising a
variety of unique manufacturing processes, including environmentally friendly
nitrogen expansion for lightweight AZOTE(®) polyolefin and ZOTEK(®)
high-performance foams, Zotefoams sells to diverse markets worldwide.
Zotefoams uses its own cellular materials to manufacture T-FIT(®) advanced
insulation for demanding industrial markets. Zotefoams also owns and licenses
patented microcellular foam technology to reduce plastic use in extrusion
applications and for ReZorce(®) mono-material recyclable barrier packaging.

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites
in Kentucky, USA and Brzeg, Poland (foam manufacture), Oklahoma, USA (foam
products manufacture and conversion), Massachusetts, USA and Stilling, Denmark
(microcellular foam technology) and Jiangsu Province, China (T-FIT).

www.zotefoams.com (http://www.zotefoams.com)

AZOTE(®), ZOTEK(®), ReZorce(®) and T-FIT(®) are registered trademarks of
Zotefoams plc.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCSFFFDWEDSEFW